ALA's EV now 25-30x that of CHM having not one clinical trial running and hardly any $ left. If they got valued correctly, CHM's and especially IMU's MC should be in the billions. The strange ASX valuations are continuing.
GLTA
ALA's EV now 25-30x that of CHM having not one clinical trial...
Add CHM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.7¢ |
Change
0.001(6.25%) |
Mkt cap ! $14.66M | |||
| Open | High | Low | Value | Volume |
| 1.6¢ | 1.7¢ | 1.6¢ | $24.72K | 1.459M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 2303246 | 1.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.8¢ | 6238 | 1 |
View Market Depth
| Last trade - 16.10pm 07/06/2024 (20 minute delay) ? |
|
|||||
|
Last
1.7¢ |
Change
0.001 ( 6.25 %) |
||||
| Open | High | Low | Volume | ||
| 1.7¢ | 1.8¢ | 1.7¢ | 1329876 | ||
| Last updated 15.59pm 07/06/2024 ? | |||||
| CHM (ASX) Chart |